Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06595966
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exploratory Research on Constructing a Computational Biological Model Based on Next Generation Sequencing Technology for Monitoring Measurable Residual Disease MRD After Breast Cancer Surgery
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will include 80 subjects after radical breast cancer resection collect blood samples of the above subjects observe and quantify the characteristic changes of cfDNA in the blood of breast cancer subjects after surgery and establish a computational biological model based on next generation sequencing to monitor breast cancer MRD
Detailed Description:
This study will include 80 subjects after radical breast cancer resection The results of CA15-3 CEA color Doppler ultrasound and other traditional postoperative monitoring examinations for breast cancer as well as 5ml of peripheral venous blood were collected on the day of enrollmentthe 7th day after adjuvant treatmentthe 3rd 6th 9th 12th 15th 18th 21st 24th 30th and 36th months after surgery We observe and quantify the characteristic changes of cfDNA in the blood of breast cancer subjects after surgery and establish a computational biological model based on next generation sequencing to monitor breast cancer MRD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None